Stay updated on Modakafusp Alfa + Daratumumab in MM Clinical Trial
Sign up to get notified when there's something new on the Modakafusp Alfa + Daratumumab in MM Clinical Trial page.

Latest updates to the Modakafusp Alfa + Daratumumab in MM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the history list, updating the page's revision log.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedSite revision updated to v3.4.3 (v3.4.2 removed).SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision v3.4.2 was added, replacing the previous v3.4.1 in the record history, indicating a minor metadata/UI update. No substantive changes to study data, status, or content are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedRevision: v3.4.1 was added; the funding-status notice was removed and the prior v3.4.0 entry is no longer shown. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check69 days agoChange DetectedTeva Branded Pharmaceutical Products R&D LLC is added as sponsor/collaborator and related entities are updated with new dates; Takeda is removed as sponsor/collaborator.SummaryDifference1%

- Check76 days agoChange DetectedUI updates include a glossary toggle and color-coded change indicators (green for additions, red for deletions) with the new Revision: v3.4.0, replacing the previous v3.3.4.SummaryDifference0.8%

Stay in the know with updates to Modakafusp Alfa + Daratumumab in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Modakafusp Alfa + Daratumumab in MM Clinical Trial page.